Table: Taisho Pharmaceutical HD - 6-MTH group results
Oct 30 (Reuters)-
Taisho Pharmaceutical Holdings Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2017 Sep 30, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 138.63 141.01 279.00
(-1.7 pct) (-3.4 pct) (-0.3 pct)
Operating 15.18 16.66 28.50
(-8.9 pct) (+19.6 pct) (-10.8 pct)
Recurring 17.85 19.13 34.50
(-6.7 pct) (+8.2 pct) (-9.3 pct)
Net 12.02 13.50 24.00
(-11.0 pct) (+19.7 pct) (-16.6 pct)
EPS 150.38 yen 168.93 yen 300.38 yen
EPS Diluted 150.26 yen 168.82 yen
Ann Div 110.00 yen 110.00 yen
-Q2 div 50.00 yen 50.00 yen
-Q4 div 60.00 yen 60.00 yen
NOTE - Taisho Pharmaceutical Holdings Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Taisho Pharmaceutical Holdings Co
See all newsBrief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Squeeze Out Price If Taisho Disagrees With Their Demand - Nikkei
Brief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Tender Offer Price If Taisho Disagrees Their Demand - Nikkei
Activist fund Oasis says it may take legal action over Taisho's management buyout
Brief: Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout
To Retire Treasury Shares Worth 3.65% Of Outstanding Stock On April 10